MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-09-2026
Becton, Dickinson and Company Cash and Cash Equivalents 2011-2026 | BDX
Annual Cash and Cash Equivalents Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 641 M | 1.72 B | 1.48 B | 1.16 B | 2.39 B | 2.92 B | 536 M | 1.14 B | 14.2 B | 1.54 B | 1.42 B | 1.86 B | 1.89 B | 1.67 B | 1.18 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.2 B | 536 M | 2.38 B |
Quarterly Cash and Cash Equivalents Becton, Dickinson and Company
| 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 740 M | 735 M | 667 M | 813 M | 4.49 B | 2.39 B | 1.23 B | 1.02 B | 2.07 B | 744 M | 1.01 B | 2.76 B | 3.32 B | 2.05 B | 2.28 B | 3.15 B | 2.28 B | 3.25 B | 2.82 B | 2.82 B | 2.82 B | 560 M | 536 M | 536 M | 536 M | 943 M | 1.14 B | 1.14 B | 1.14 B | 1.12 B | 14.2 B | 14.2 B | 14.2 B | 919 M | 1.54 B | 1.54 B | 919 M | 1.58 B | 1.42 B | 1.42 B | 1.58 B | 8.54 B | 1.86 B | 1.86 B | 8.54 B | 1.68 B | 1.89 B | 1.89 B | 1.68 B | 1.92 B | 1.67 B | 1.67 B | 1.92 B | 2.2 B | 1.18 B | 1.18 B | 2.2 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.2 B | 536 M | 2.57 B |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
iRhythm Technologies
IRTC
|
236 M | $ 127.48 | 4.19 % | $ 4.08 B | USA |
 |
Repro Med Systems
KRMD
|
8.87 M | $ 4.05 | 2.27 % | $ 187 M | USA |
 |
Microbot Medical
MBOT
|
3.91 M | $ 2.18 | -0.91 % | $ 99.8 M |  Israel |
 |
Milestone Scientific
MLSS
|
1.11 M | $ 0.32 | - | $ 26.3 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.21 B | $ 27.04 | 0.9 % | $ 4.54 B | USA |
 |
Alcon
ALC
|
1.53 B | $ 76.34 | 0.73 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
1.17 M | $ 11.26 | 0.72 % | $ 27.3 M | USA |
 |
STERIS plc
STE
|
172 M | $ 222.0 | 0.09 % | $ 21.9 B | USA |
 |
The Cooper Companies
COO
|
111 M | $ 64.91 | 0.76 % | $ 12.9 B | USA |
 |
Teleflex Incorporated
TFX
|
379 M | $ 136.61 | 0.04 % | $ 6.1 B | USA |
 |
Utah Medical Products
UTMD
|
85.8 M | $ 67.71 | 0.8 % | $ 219 M | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 60.24 | 0.52 % | $ 3.03 B | USA |
 |
electroCore
ECOR
|
7.04 M | $ 6.37 | 3.11 % | $ 54 K | USA |
 |
ICU Medical
ICUI
|
308 M | $ 123.66 | -0.93 % | $ 3.05 B | USA |
 |
Isoray
ISR
|
30.6 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.37 B | $ 481.38 | -0.18 % | $ 172 B | USA |
 |
West Pharmaceutical Services
WST
|
791 M | $ 306.32 | 0.14 % | $ 22.1 B | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 123.44 | 1.61 % | $ 5.98 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 178.66 | 0.02 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 10.83 | 4.74 % | $ 224 M | USA |
 |
Merit Medical Systems
MMSI
|
446 M | $ 68.08 | -0.73 % | $ 4.03 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 22.88 | -0.61 % | $ 1.54 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
326 M | $ 12.04 | 1.05 % | $ 2.4 B | USA |
 |
Retractable Technologies
RVP
|
2.59 M | $ 0.62 | -4.3 % | $ 18.6 M | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 52.01 | -0.17 % | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
28.2 M | $ 114.43 | 0.86 % | $ 2.59 B | USA |
 |
Predictive Oncology
POAI
|
10.8 M | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
153 M | $ 26.37 | 2.73 % | $ 1.31 B | USA |
 |
BioLife Solutions
BLFS
|
95.4 M | $ 21.8 | 1.96 % | $ 1 B | USA |
 |
Stereotaxis
STXS
|
13.4 M | $ 1.93 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
1.97 B | $ 18.36 | 1.16 % | $ 9.42 B | USA |
 |
ResMed
RMD
|
274 M | $ 220.37 | 0.24 % | $ 32.2 B | USA |
 |
AtriCure
ATRC
|
167 M | $ 29.33 | 0.17 % | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
8.61 M | $ 6.72 | -2.04 % | $ 298 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 11.24 | 1.26 % | $ 459 M | USA |
 |
Nephros
NEPH
|
4.31 M | $ 3.03 | 5.4 % | $ 31.5 M | USA |
 |
OraSure Technologies
OSUR
|
199 M | $ 3.03 | 0.83 % | $ 223 M | USA |
 |
Repligen Corporation
RGEN
|
751 M | $ 118.26 | 0.56 % | $ 6.59 M | USA |